Eyenovia's Series C Round

Eyenovia raised a round of funding on August 14, 2017.

Eyenovia is a specialty biopharmaceutical company building a portfolio of next generation eye therapies based on its proprietary delivery and formulation platform for microdosed therapies. Founded by …

Articles about Eyenovia's Series C Round: